Does angiotensin blockade influence graft outcome in renal transplant recipients with IgA nephropathy?
| Data(s) |
01/12/2006
|
|---|---|
| Resumo |
IgA nephropathy (IgAN) is a frequent cause of end-stage renal disease (ESRD) and recurrent disease causes deterioration and graft loss in transplant recipients. No definitive management is known to reduce the risk or severity of recurrent IgAN, and the evidence to support the use of renin-angiotensin system blockade in such patients is limited. |
| Identificador | |
| Idioma(s) |
eng |
| Direitos |
info:eu-repo/semantics/restrictedAccess |
| Fonte |
Courtney , A E , McNamee , P T , Nelson , W E & Maxwell , A P 2006 , ' Does angiotensin blockade influence graft outcome in renal transplant recipients with IgA nephropathy? ' Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association , vol 21 , no. 12 , pp. 3550-4 . DOI: 10.1093/ndt/gfl506 |
| Palavras-Chave | #/dk/atira/pure/subjectarea/asjc/2700/2727 #Nephrology #/dk/atira/pure/subjectarea/asjc/2700/2747 #Transplantation |
| Tipo |
article |
